Neon Therapeutics, Inc. (NTGN)

Trade NTGN now with
7/15/2019 6:10:38 AM Neon Therapeutics Reports Top-line Results From Phase 1b Clinical Trial On NEO-PV-01 In Combination With OPDIVO
1/3/2019 7:10:58 AM Neon Therapeutics Provides Business Update For 2019
12/6/2018 7:14:11 AM Neon Therapeutics And Apexigen Announce First Patient Dosed In Neon’s NT-003 Phase 1b Combination Trial Of NEO-PV-01
11/12/2018 4:20:22 PM Neon Therapeutics Q3 Loss/share $0.67 Vs. Loss $9.59 Year Ago
10/22/2018 6:01:07 AM Neon Therapeutics Presents Data From Ongoing Phase 1b NT-001 Clinical Trial At ESMO 2018 Congress
8/21/2018 4:24:52 PM Neon Therapeutics Appoints Jolie Siegel As General Counsel